Technical Analysis for NEXI - NexImmune, Inc.

Grade Last Price % Change Price Change
F 18.71 1.46% 0.27
NEXI closed up 1.46 percent on Wednesday, May 5, 2021, on 40 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical NEXI trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 20 DMA Bearish 1.46%
Oversold Stochastic Weakness 1.46%
Crossed Above 20 DMA Bullish -4.88%
Stochastic Reached Oversold Weakness -4.88%
Oversold Stochastic Weakness -4.88%
Fell Below 20 DMA Bearish -3.11%
Older End-of-Day Signals for NEXI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day about 8 hours ago
60 Minute Opening Range Breakout about 10 hours ago
Up 1% about 10 hours ago
Down 1% about 12 hours ago
60 Minute Opening Range Breakdown 1 day ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation (AIM) technology. The company has two product candidates in human trials, including NEXI-001 in acute myeloid leukemia, or AML; and NEXI-002 in multiple myeloma, or MM. NexImmune, Inc. was founded in 2011 and is headquartered in Gaithersburg, Maryland.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Immunotherapy Acute Myeloid Leukemia Immunotherapies Leukemia Multiple Myeloma Immune Mediated Diseases

Is NEXI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 28.0
52 Week Low 17.06
Average Volume 106,035
200-Day Moving Average 0.00
50-Day Moving Average 20.38
20-Day Moving Average 19.34
10-Day Moving Average 19.20
Average True Range 1.62
ADX 17.08
+DI 22.66
-DI 18.45
Chandelier Exit (Long, 3 ATRs ) 21.63
Chandelier Exit (Short, 3 ATRs ) 22.13
Upper Bollinger Band 21.99
Lower Bollinger Band 16.69
Percent B (%b) 0.38
BandWidth 27.41
MACD Line -0.37
MACD Signal Line -0.41
MACD Histogram 0.0431
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.93
Resistance 3 (R3) 19.88 19.44 19.72
Resistance 2 (R2) 19.44 19.13 19.46 19.65
Resistance 1 (R1) 19.07 18.94 19.26 19.12 19.59
Pivot Point 18.63 18.63 18.72 18.65 18.63
Support 1 (S1) 18.26 18.32 18.45 18.31 17.83
Support 2 (S2) 17.82 18.13 17.84 17.77
Support 3 (S3) 17.45 17.82 17.70
Support 4 (S4) 17.50